de Swart, M E, Kouwenhoven, M C M, Hellingman, T, Kuiper, B I, Gorter de Vries, C, Leembruggen-Vellinga, M, Maliepaard, N K, Wouda, E J, Moraal, B, Noske, D P, Postma, T J, Sanchez Aliaga, E, Uitdehaag, B M J, Vandertop, W P, Zonderhuis, B M, Kazemier, G, de Witt Hamer, P C & Schuur, M 2021, ' A multidisciplinary neuro-oncological triage panel reduces the time to referral and treatment for patients with a brain tumor ', Neuro-Oncology Practice, vol. 8, no. 5, pp. 559-568 . https://doi.org/10.1093/nop/npab040 Neuro-oncology practice, 8(5), 559-568. Oxford University Press Neuro-Oncology Practice, 8(5), 559-568. Oxford University Press Neuro-Oncology Practice
Health Informatics Journal, 29(1). SAGE Publications Ltd de Swart, M E, Zonderhuis, B M, Hellingman, T, Kuiper, B I, Dickhoff, C, Heineman, D J, Hendrickx, J J, Kouwenhoven, M C M, van Moorselaar, R J A, Schuur, M, Tenhagen, M, van der Velde, S, de Witt Hamer, P C, Zijlstra, J M & Kazemier, G 2023, ' Incomplete patient information exchange and unnecessary repeat diagnostics during oncological referrals in the Netherlands : exploring the role of information exchange ', Health Informatics Journal, vol. 29, no. 1 . https://doi.org/10.1177/14604582231153795
Brahm, C G, van Linde, M E, Enting, R H, Schuur, M, Otten, R H J, Heymans, M W, Verheul, H M W & Walenkamp, A M E 2020, ' The Current Status of Immune Checkpoint Inhibitors in Neuro-Oncology : A Systematic Review ', Cancers, vol. 12, no. 3, 586 . https://doi.org/10.3390/cancers12030586 Cancers Cancers, Vol 12, Iss 3, p 586 (2020) Cancers, 12 Cancers, 12, 3
BMC Medical Genetics, 11, pp. 162-162 Combarros, O, Warden, D R, Hammond, N, Cortina-Borja, M, Belbin, O, Lehmann, M G, Wilcock, G K, Brown, K, Kehoe, P G, Barber, R, Coto, E, Alvarez, V, Deloukas, P, Gwilliam, R, Heun, R, Kölsch, H, Mateo, I, Oulhaj, A, Arias-Vásquez, A, Schuur, M, Aulchenko, Y S, Ikram, M A, Breteler, M M, van Duijn, C M, Morgan, K, Smith, A D & Lehmann, D J 2010, ' The dopamine β-hydroxylase-1021C/T polymorphism is associated with the risk of Alzheimer's disease in the Epistasis Project ', BMC Medical Genetics, vol. 11, no. 1, 162 . https://doi.org/10.1186/1471-2350-11-162 BMC Medical Genetics, 11, 162-162 BMC Medical Genetics, Vol 11, Iss 1, p 162 (2010) BMC Medical Genetics, 11. BioMed Central Ltd. BMC Medical Genetics. 2010 Nov 11;11:162 UCrea Repositorio Abierto de la Universidad de Cantabria Universidad de Cantabria (UC) BMC Medical Genetics, 11(1):162. BioMed Central BMC Medical Genetics
Molecular Psychiatry, 21(2), 189-197. Nature Publishing Group Molecular Psychiatry, 21(2), 189-197 Ibrahim-Verbaas, C A, Bressler, J, Debette, S, Schuur, M, Smith, A V, Bis, J C, Davies, G, Trompet, S, Smith, J A, Wolf, C, Chibnik, L B, Liu, Y, Vitart, V, Kirin, M, Petrovic, K, Polasek, O, Zgaga, L, Fawns-Ritchie, C, Hoffmann, P, Karjalainen, J, Lahti, J, Llewellyn, D J, Schmidt, C O, Mather, K A, Chouraki, V, Sun, Q, Resnick, S M, Rose, L M, Oldmeadow, C, Stewart, M, Smith, B H, Gudnason, V, Yang, Q, Mirza, S S, Jukema, J W, deJager, P L, Harris, T B, Liewald, D, Amin, N, Gow, A J, Pattie, A, Starr, J M, McLachlan, S, Porteous, D J, Price, J F, Rudan, I, Hayward, C, Wright, A F & Wilson, J F & Deary, I 2016, ' GWAS for executive function and processing speed suggests involvement of the CADM2 gene ', Molecular Psychiatry, vol. 21, pp. 189-197 . https://doi.org/10.1038/mp.2015.37 Ibrahim-Verbaas, CA; Bressler, J; Debette, S; Schuur, M; Smith, AV; Bis, JC; et al.(2016). GWAS for executive function and processing speed suggests involvement of the CADM2 gene. MOLECULAR PSYCHIATRY, 21(2), 189-197. doi: 10.1038/mp.2015.37. UCLA: Retrieved from: http://www.escholarship.org/uc/item/7d8152n1 Molecular psychiatry 21(2), 189-197 (2015). doi:10.1038/mp.2015.37 Neurology Working Group of the CHARGE Consortium 2016, ' GWAS for executive function and processing speed suggests involvement of the CADM2 gene ', Molecular Psychiatry, vol. 21, no. 2, pp. 189-197 . https://doi.org/10.1038/mp.2015.37 Molecular psychiatry 21, 189–197 (2016). doi:10.1038/mp.2015.37
European Journal of Epidemiology, 28(2), 131-138. Springer Netherlands European Journal of Epidemiology, 28(2), 131-8. Springer Netherlands Broer, L, Lill, C M, Schuur, M, Amin, N, Roehr, J T, Bertram, L, Ioannidis, J P A & van Duijn, C M 2013, ' Distinguishing true from false positives in genomic studies : p values ', European Journal of Epidemiology, vol. 28, no. 2, pp. 131-8 . https://doi.org/10.1007/s10654-012-9755-x
Coppus, A M W, Schuur, M, Vergeer, J, Janssens, A C J W, Oostra, B A, Verbeek, M M & van Duijn, C M 2012, ' Plasma β amyloid and the risk of Alzheimer's disease in Down syndrome ', Neurobiology of Aging, vol. 33, no. 9, pp. 1988-1994 . https://doi.org/10.1016/j.neurobiolaging.2011.08.007 Neurobiology of Aging, 33, 1988-94 Neurobiology of Aging, 33(9), 1988-1994. Elsevier Inc. Neurobiology of Aging, 33, 9, pp. 1988-94